Jump Financial, LLC Acadia Pharmaceuticals Inc Transaction History

Jump Financial, LLC

$4.3 Billion
Q4 2024

A detailed history of Jump Financial, LLC transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Jump Financial, LLC holds 154,006 shares of ACAD stock, worth $3.07 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

154,006

Previous 166,388 7.44%

Holding current value

$3.07 Million

Previous $2.56 Million 10.39%

% of portfolio

0.07%

Previous 0.06%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	SELL	$14.29 - $18.76 $176,938 - $232,286	-12,382 Reduced 7.44%	154,006 $2.83 Million
Q3 2024 Nov 14, 2024	BUY	$15.14 - $19.14 $1.89 Million - $2.39 Million	124,618 Added 298.34%	166,388 $2.56 Million
Q2 2024 Aug 14, 2024	SELL	$14.62 - $18.42 $1.57 Million - $1.98 Million	-107,233 Reduced 71.97%	41,770 $678,000
Q1 2024 May 13, 2024	BUY	$17.79 - $30.86 $581,056 - $1.01 Million	32,662 Added 28.07%	149,003 $2.76 Million
Q4 2023 Oct 21, 2024	BUY	$20.78 - $31.77 $1.85 Million - $2.83 Million	89,053 Added 326.34%	116,341 $3.64 Million
Q4 2023 Feb 07, 2024	BUY	$20.78 - $31.77 $1.85 Million - $2.83 Million	89,053 Added 326.34%	116,341 $3.64 Million
Q3 2023 Oct 21, 2024	SELL	$20.84 - $33.47 $1.05 Million - $1.69 Million	-50,401 Reduced 64.88%	27,288 $568,000
Q3 2023 Nov 07, 2023	SELL	$20.84 - $33.47 $1.05 Million - $1.69 Million	-50,401 Reduced 64.88%	27,288 $568,000
Q2 2023 Oct 21, 2024	SELL	$17.8 - $25.65 $2.12 Million - $3.06 Million	-119,221 Reduced 60.55%	77,689 $1.86 Million
Q2 2023 Aug 07, 2023	SELL	$17.8 - $25.65 $2.12 Million - $3.06 Million	-119,221 Reduced 60.55%	77,689 $1.86 Million
Q1 2023 Oct 21, 2024	BUY	$16.32 - $20.92 $2.53 Million - $3.25 Million	155,140 Added 371.41%	196,910 $3.71 Million
Q1 2023 May 03, 2023	BUY	$16.32 - $20.92 $3.21 Million - $4.12 Million	196,910 New	196,910 $3.71 Million
Q3 2022 Nov 07, 2022	SELL	$14.11 - $18.27 $1.8 Million - $2.33 Million	-127,669 Reduced 90.69%	13,100 $214,000
Q2 2022 Aug 09, 2022	BUY	$13.01 - $27.22 $969,570 - $2.03 Million	74,525 Added 112.5%	140,769 $1.98 Million
Q1 2022 May 12, 2022	BUY	$20.94 - $27.5 $1.39 Million - $1.82 Million	66,244 New	66,244 $1.6 Million
Q3 2021 Nov 12, 2021	SELL	$15.78 - $24.77 $1.25 Million - $1.96 Million	-79,060 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$19.4 - $27.42 $1.53 Million - $2.17 Million	79,060 New	79,060 $1.93 Million

Others Institutions Holding ACAD

# of Institutions

316

Shares Held

164M

Call Options Held

855K

Put Options Held

350K

View Full List

About ACADIA PHARMACEUTICALS INC

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $3.23B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

More about ACAD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jump Financial, LLC with notifications on news.

Account

Jump Financial, LLC Acadia Pharmaceuticals Inc Transaction History